Topic

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Articles

The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.

This Again?

The author describes the development of small-angle X-ray scattering and analyzes its advantages in the characterization of drug-delivery systems and large molecules. This article is part of a special Analytical Technology issue.

Small-Angle X-ray Scattering for Pharmaceutical Applications

Novartis Sells US Enablex Rights; Ricerca Names Chemistry Director; And More.

Week of Sept. 27, 2010: Company and People Notes: Novartis Sells US Enablex Rights; Ricerca Names Chemistry Director; And More.

DSM and PolyTherics in Development Deal; Kite Pharma Appoints President and CEO, And More.

Week of Sept. 20, 2010: Company and People Notes: DSM and PolyTherics in Development Deal; Kite Pharma Appoints President and CEO, And More.

Genzyme Sells Genetics Business; Bausch and Lomb Names Vice-President; and More.

Week of Sept. 13, 2010: Company and People Notes: Genzyme Sells Genetics Business; Bausch and Lomb Names Vice-President; and More.

Pfizer to Acquire FoldRx; Protalix Appoints COO; And More.

Week of Sept. 6, 2010: Company and People Notes: Pfizer to Acquire FoldRx; Protalix Appoints COO; And More.

Editors' picks of pharmaceutical science and technology innovations.

In the Spotlight Editor's Picks

Company and People Notes: Lonza Acquired Vivante; PPD Appoints VP of Quality Management; And More.

Week of Aug. 30, 2010: Company and People Notes: Lonza Acquires Vivante; PPD Appoints VP of Quality Management; And More.

Software and online monitoring are helping the pharmaceutical industry improve its corrective and preventive action programs. This article contains bonus online material.

Going Digital

PharmTech talked to anticounterfeiting experts to discuss terrorism as a source of counterfeit products.

Data and Artificial Intelligence